Mini Drug Pump for Ophthalmic Use

REFERENCES

• Geroski DH, Edelhauser HF. Drug delivery for posterior segment eye disease. Invest Ophthalmol Vis Sci 2000;41:961–964.
   PubMed Web of Science ®Google Scholar
• Hoyng PF, van Beek LM. Pharmacological therapy for glaucoma: A review. Drugs 2000;59:411–434.
   PubMed Web of Science ®Google Scholar
• Hsu J. Drug delivery methods for posterior segment disease. Curr Opin Ophthalmol 2007;18:235–239.
   PubMed Web of Science ®Google Scholar
• Shell JW. Ophthalmic drug delivery systems. Surv Ophthalmol 1984;29:117–128.
   PubMed Web of Science ®Google Scholar
• Davies NM. Biopharmaceutical considerations in topical ocular drug delivery. Clin Exp Pharmacol Physiol 2000;27:558–562.
   PubMed Web of Science ®Google Scholar
• Sultana Y, Jain R, Aqil M, et al. Review of ocular drug delivery. Curr Drug Deliv 2006;3:207–217.
   PubMedGoogle Scholar
• Bourlais CL, Acar L, Zia H, et al. Ophthalmic drug delivery systems—Recent advances. Prog Retin Eye Res 1998;17:33–58.
   PubMed Web of Science ®Google Scholar
• Metrikin DC, Anand R. Intravitreal drug administration with depot devices. Curr Opin Ophthamol 1994;5:21–29.
   PubMedGoogle Scholar
• Ho QT, Kuo CJ. Vascular endothelial growth factor: Biology and therapeutic applications. Int J Biochem Cell Bio 2007;39:1349–1357.
   PubMed Web of Science ®Google Scholar
• Lloyd R, Harris J, Wadhwa S, et al. Food and Drug Administration approval process for ophthalmic drugs in the US. Curr Opin Ophthalmol 2008;19:190–194.
   Google Scholar
• Ozkiris A, Erkilic K. Complications of intravitreal injection of triamcinolone acetonide. Can J Ophthalmol 2005;40:63–68.
   PubMed Web of Science ®Google Scholar
• Li P-Y, Shih J, Lo R, et al. An electrochemical intraocular drug delivery device. Sensors and Actuators A: Physical 2008;143:41–48.
   Web of Science ®Google Scholar
• Lo R, Li P-Y, Agrawal RN, et al. A passive refillable intraocular MEMS drug delivery device. Lab on a Chip 2008;8:1027–1030.
   PubMed Web of Science ®Google Scholar
• Agrawal RN, He S, Spee C, et al. In vivo models of proliferative vitreoretinopathy. Nat Protoc 2007;2:67–77.
   PubMed Web of Science ®Google Scholar
• Lattanzio FA, Jr., Sheppard JD, Jr., Allen RC, et al. Do injections of 5-fluorouracil after trabeculectomy have toxic effects on the anterior segment? J Ocul Pharmacol Ther 2005;21:223–235.
   Google Scholar
• Lad EM, Moshfeghi DM. Minimizing the risk of endophthalmitis following intravitreal injections. Compr Ophthalmol Update 2006;7:277–284; discussion 285–276.
   PubMedGoogle Scholar
• Avery RL, Pearlman J, Pieramici DJ, et al. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 2006;113:1695 e1–e15.
   PubMed Web of Science ®Google Scholar
• Bashshur ZF, Bazarbachi A, Schakal A, et al. Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration. Am J Ophthalmol 2006;142:1–9.
   PubMed Web of Science ®Google Scholar
• Costa RA, Jorge R, Calucci D, et al. Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions: IBeVO study. Retina 2007;27:141–149.
   PubMed Web of Science ®Google Scholar
• Dash AK, Cudworth GC, 2nd. Therapeutic applications of implantable drug delivery systems. J Pharmacol Toxicol Methods 1998;40:1–12.
   PubMed Web of Science ®Google Scholar
• Ambati J, Gragoudas ES, Miller JW, et al. Transscleral delivery of bioactive protein to the choroid and retina. Invest Ophthalmol Vis Sci 2000;41:1186–1191.
   PubMed Web of Science ®Google Scholar
• Berg AVD, Lammerink TSJ. Micro total analysis systems: Microfluidic aspects, integration concept and applications. Microcys Technol Chem Life Sci Topic Curr Chem 1998;194:21–49.
   Google Scholar
• Shoji S. Fluids for sensor systems. Topics Curr Chem 1998;194:163–188.
   Google Scholar
• Vilkner T, Janasek D, Manz A.Micro total analysis systems. Recent developments. Analyt Chem 2004;76:3373–3385.
   PubMed Web of Science ®Google Scholar
• Razzacki SZ, Thwar PK, Yang M, et al. Integrated microsystems for controlled drug delivery. Adv Drug Deliv Rev 2004;56:185–198.
   PubMed Web of Science ®Google Scholar
• Richards Grayson AC, Scheidt Shawgo R, Li Y, et al. Electronic MEMS for triggered delivery. Adv Drug Deliv Rev 2004;56:173–184.
   PubMed Web of Science ®Google Scholar
• Rodger DC, Wieland JD, Humayun MS, et al. Scalable high lead-count parylene package for retinal prostheses. Sensors and Actuators B: Chemical 2006;117:107–114.
   Google Scholar
• Wu HK, Huang B, Zare RN. Construction of microfluidic chips using polydimethylsiloxane for adhesive bonding. Lab on a Chip 2005;5:1393–1398.
   PubMedGoogle Scholar
• Phillip M, Battelino T, Rodriguez H, et al. Use of insulin pump therapy in the pediatric age-group: Consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2007;30:1653–1662.
   PubMed Web of Science ®Google Scholar
• Ronn B, Mathiesen ER, Vang L, et al. Evaluation of insulin pump treatment under routine conditions. Diabetes Res Clin Pract 1987;3:191–196.
   Google Scholar
• Kim CS, Yim JH, Lee EK, et al. Changes in corneal endothelial cell density and morphology after Ahmed glaucoma valve implantation during the first year of follow up. Clin Experiment Ophthalmol 2008;36:142–147.
   Web of Science ®Google Scholar
• Lim KS. Corneal endothelial cell damage from glaucoma drainage device materials. Cornea 2003;22:352–354.
   Google Scholar
• van Dooren BT, Beekhuis WH, Pels E. Biocompatibility of trypan blue with human corneal cells. Arch Ophthalmol 2004;122:736–742.
   PubMedGoogle Scholar
• Gloor B, Gloor ML, Merz-Hill M, et al. Wound healing of the corneal posterior surface in animal experiments. Klin Monatsbl Augenheilkd 1986;188:225–230.
   Google Scholar
• Ichijima H, Petroll WM, Jester JV, et al. In vivo confocal microscopic studies of endothelial wound healing in rabbit cornea. Cornea 1993;12:369–378.
   PubMedGoogle Scholar
• Olsen EG, Davanger M. The healing of rabbit corneal endothelium. Acta Ophthalmol (Copenh) 1984;62:796–807.
   Web of Science ®Google Scholar
• Van Horn DL, Sendele DD, Seideman S, et al. Regenerative capacity of the corneal endothelium in rabbit and cat. Invest Ophthalmol Vis Sci 1977;16:597–613.
   PubMed Web of Science ®Google Scholar